Status:
COMPLETED
Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section
Lead Sponsor:
Menoufia University
Conditions:
Cesarean Section
Spinal Anesthesia
Eligibility:
FEMALE
18-35 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this study is to evaluate the effectiveness of low dose scheme with dexmedetomidine as an adjuvant. Taking in consideration optimum intraoperative surgical conditions, best post-operative p...
Eligibility Criteria
Inclusion
- Full-term pregnant women
- Singleton gestation
- American Society of Anaesthesiologists (ASA) physical status classes II and I
Exclusion
- Preterm pregnancy (\<37 wks. gestation)
- Multiple gestation
- Cardiovascular disease (e.g., preeclampsia, hypertension) and the use of antihypertensive medications
- Asthma and allergy to non-steroidal anti-inflammatory drugs
- Conditions that prevent spinal anaesthesia
- Failed spinal block and conversion to general anaesthesia
- A history of established chronic pain
- Drug addiction
- A psychiatric disorder
- Inability to communicate effectively
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03775655
Start Date
September 1 2018
End Date
January 10 2019
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Menoufia University Hospitals
Shibīn al Kawm, Menoufia, Egypt